Watch CPHI. Know when insiders buy.
One email the day a filing lands. Free.
CPHI
CHINA PHARMA HOLDINGS, INC.
0.76
−0.02 −2.56%
USD · close Sep 10
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $32.7MP/E —DIV YIELD —FCF YIELD —REV TTM $3.9M −11.0%NET INCOME −$4.5MNET DEBT $4M52W 0.52 – 8.10SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $948K | −7.5% | 8.8% | −$1.4M | −$1.5M | — | -0.04 | −$33K | — | — | Aug 14 |
| Q1 2026 · Mar 31 | $984K | −13.4% | 29.0% | −$1.1M | −$1.1M | — | -0.04 | −$55K | — | — | Aug 14 |
| Q4 2025 · Dec 31derived | $1.2M | +8.1% | 12.3% | −$1.2M | −$1.2M | — | -0.17 | $152K | $454 | $152K | Apr 1 |
| Q3 2025 · Sep 30 | $756K | −31.3% | -7.9% | −$628K | −$651K | — | -0.17 | −$204K | $611 | −$205K | Nov 12 |
| Q2 2025 · Jun 30 | $1M | +10.9% | -8.5% | −$652K | −$528K | — | -0.16 | $274K | −$65 | $274K | Aug 14 |
| Q1 2025 · Mar 31 | $1.1M | −17.0% | -12.0% | −$759K | −$786K | — | -0.24 | −$74K | $58K | −$132K | Aug 14 |
| Q4 2024 · Dec 31derived | $1.1M | −47.2% | -14.2% | −$1.2M | −$1.2M | — | -0.46 | $299K | $20K | $279K | Apr 1 |
| Q3 2024 · Sep 30 | $1.1M | −39.0% | -47.2% | −$1.1M | −$1.1M | — | -0.65 | −$47K | −$9K | −$38K | Nov 12 |
| Q2 2024 · Jun 30 | $925K | — | -109.8% | −$1.4M | −$1.4M | — | -0.89 | −$73K | — | — | Nov 12 |
| Q1 2024 · Mar 31 | $1.4M | — | -21.2% | −$916K | −$956K | — | -0.72 | −$585K | — | — | Nov 12 |
| Q4 2023 · Dec 31derived | $2.1M | — | -3.7% | −$1.2M | −$1.2M | — | -0.02 | −$22K | — | — | Mar 31 |
| Q3 2023 · Sep 30 | $1.8M | — | -12.9% | −$714K | −$778K | — | -0.29 | $1M | — | — | Nov 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $4.1M | -3.2% | −$3.2M | −$3.2M | -76.9% | -0.74 | $148K | $59K | $89K | — | — |
| FY2024 · to Dec 31 | $4.5M | -43.8% | −$4.6M | −$4.7M | -104.6% | -2.71 | −$406K | $38K | −$444K | — | — |
| FY2023 · to Dec 31 | $7M | -4.0% | −$2.8M | −$3.1M | -43.9% | -0.91 | −$700K | $12K | −$711K | — | — |
| FY2022 · to Dec 31 | $8.1M | -6.1% | −$3.5M | −$4M | -49.0% | -3.78 | −$410K | $402K | −$812K | — | — |
| FY2021 · to Dec 31 | $9.6M | 3.6% | −$2.9M | −$3.4M | -35.3% | -0.74 | −$250K | $438K | −$688K | — | — |
| FY2020 · to Dec 31 | $10.9M | 18.0% | −$2.6M | −$2.9M | -26.4% | -0.07 | −$42K | $867K | −$910K | — | — |
Every number comes from CHINA PHARMA HOLDINGS, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.